ENDOTAK RELIANCE
Report
- Report Number
- 2124215-2012-16415
- Event Type
- Malfunction
- Date Received
- January 11, 2013
- Date of Event
- November 21, 2012
- Report Date
- November 21, 2012
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVY
- PMA / PMN Number
- P910073
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
AS NO FURTHER CURRENT INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A ROUTINE VISIT, THE INITIAL INTERROGATION PRESENTED A LEAD IMPEDANCE ALERT FOR THE SUMMARY PAGE. INSPECTION OF THE RIGHT VENTRICULAR (RV) LEAD DATA REVEALED STABLE SENSING AND PACING IMPEDANCE MEASUREMENTS, WITH AN INITIALLY STABLE SHOCK IMPEDANCE MEASUREMENT OF APPROXIMATELY 40OHMS UNTIL JUNE 2012, WHEN IT BECAME ELEVATED AND VARIABLE. THE SHOCK LEAD CONFIGURATION WAS INITIALLY RV>>CAN+SVC AND ACUTE LEAD TESTING REVEALED A SHOCK IMPEDANCE MEASUREMENT >125OHMS. THE SHOCK LEAD CONFIGURATION WAS REPROGRAMMED TO RV>>CAN AND THE IMPEDANCE VALUE IN THIS CONFIGURATION WAS NORMAL AT 67OHMS. THE SHOCK LEAD CONFIGURATION WAS AGAIN REPROGRAMED TO THE FINAL CONFIGURATION OF RV>>SVC AND AGAIN THE IMPEDANCE VALUE WAS >125OHMS IN THIS CONFIGURATION USING THE SVC COIL. THE PHYSICIAN WAS CONSULTED FOR DATA DISCUSSION, AND IT WAS DECIDED TO PERMANENTLY REPROGRAM THE SHOCK VECTOR TO RV>>SVC. A CONNECTOR ISSUE WITH THE DF-1 SVC PIN IS SUSPECTED. THE PATIENT WAS NOT ORIGINALLY DFT TESTED AT IMPLANT AND THE PHYSICIAN HAS ELECTED TO NOT DFT TEST WITH THE NEW SHOCK VECTOR. THE PATIENT WILL BE FOLLOWED UP IN TWO MONTHS TO CONFIRM LEAD FUNCTION. NO ADVERSE PATIENT EFFECTS WERE REPORTED IN ASSOCIATION WITH THESE OBSERVATIONS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 17246 | ENDOTAK RELIANCE | IMPLANTABLE LEAD | NVY | CPI - DEL CARIBE | 0185 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |